SNPS
SHORTINSIDER SELLCONGRESS BUYCONGRESS SELLSYNOPSYS INC
Research: Finviz ↗·Perplexity ↗
🗄 Viewing archived Q1 2026 data — frozen, no longer refreshed.
News Summary
PositiveSynopsys delivered a strong Q2 beat with 42% YoY revenue growth and raised full-year guidance to $9.67B revenue and $14.76 non-GAAP EPS, driven by successful Ansys integration and robust Design Automation segment performance. Elliott Investment Management's board seat addition and strategic divestitures (Processor IP to GlobalFoundries, Optical Solutions) demonstrate capital discipline, while expanded AI collaborations with Arm, Intel, AMD, and Microsoft position the company for long-term growth in next-generation chip design.
Funds Reducing / Exiting (3)
| Fund | Manager | Shares Held | ∆ Shares | Position Value | % of Fund | QoQ | Status |
|---|---|---|---|---|---|---|---|
| Coatue Management | Philippe Laffont | 762K | -894,600 | $302M | 1.9% | -54% | Existing |
| Glenview Capital | Larry Robbins | 0 | −48K | — | 0.5% | -100% | EXITED |
| D1 Capital | Dan Sundheim | 0 | −378K | — | 1.7% | -100% | EXITED |
Shares Held reflects quarter-end positions for partial reductions. Funds that fully exited show 0 shares held. ∆ Shares is the change from the prior quarter. % of Fund is the prior-quarter position size — how much of the book was sold down.
Insider Activity
Congressional Trading
| Member | Chamber | State | Type | Amount Range | Transaction Date | Filed | Src |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | senate | — | BUY | $1,001 - $15,000 | 2026-03-27 | 2026-07-21 | ↗ |
| Thomas H Tuberville | senate | — | SELL | $1,001 - $15,000 | 2024-05-03 | 2026-08-05 | ↗ |
Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.